Presentations

“Sitdown” with Kancera’s CEO and CSO to discuss the positive outcome of the FRACTAL study

CEO Peter Selin presents Kancera’s Q3 2023 Interim Report

CEO Peter Selin presents KANDOVA, Kancera’s ongoing clinical study in ovarian cancer